Company / EPS (Diluted)
LeMaitre Vascular EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$1.34
FY2025
5-year range
$0.88 / $1.34
FY2021-FY2025
Trend
+44.1%
vs FY2024
Sector context
#68 of 159
Health Care
What the data says
At $1.34, LeMaitre Vascular's eps (diluted) ranks #68 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $0.23 in FY2016 to $1.34 in FY2025.
Based on SEC 10-K filings.
1.34 in FY2025 with a 5-year CAGR of +3.5%.
Improved from $1.25 to $1.34 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +3.5%
- 10-Year CAGR
- -
Sector benchmark
#68 of 159 in Health CareTop 43% of 159This company $1.34 Sector average $1.67
▼
-19.7% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 44.1% year-over-year.
- Ranks #68 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 20.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.34 | +44.1% |
| FY2024 | $0.93 | -25.6% |
| FY2023 | $1.25 | +20.2% |
| FY2022 | $1.04 | +18.2% |
| FY2021 | $0.88 | -22.1% |
| FY2020 | $1.13 | +31.4% |
| FY2019 | $0.86 | +56.4% |
| FY2018 | $0.55 | +31.0% |
| FY2017 | $0.42 | +82.6% |
| FY2016 | $0.23 | +15.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026